Do you want to read an article? Please log in or register.
Optimal Duration of Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis
Helicobacter Pylori
Related content
Gastrointestinal CancerHelicobacter Pylori
Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies
Gastroenterology
Ford AC, Yuan Y, Park JY, Forman D, Moayyedi P
doi: 10.1053/j.gastro.2024.12.033
Helicobacter Pylori
Vonoprazan Dual or Triple Therapy Versus Bismuth-Quadruple Therapy as First-Line Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial
Helicobacter
Cheung KS, Lyu T, Deng Z, Han S, Ni L, Wu J, Tan JT, Qin J, Ng HY, Leung WK, Seto WK
doi: 10.1111/hel.13133
Helicobacter Pylori
The Association Between Helicobacter pylori Infection and Eosinophilic Esophagitis: Systematic Review and Meta-Analysis
Helicobacter
Gutiérrez-Ramírez L, Garcia-Dionisio SL, Feo-Ortega S, González-Cervera J, Tejera-Muñoz A, Lucendo AJ, Arias Á
doi: 10.1111/hel.70038
Helicobacter Pylori
The Increasing Trend of the Generational Helicobacter pylori-Naïve Prevalence Among Japanese Individuals Born Between 1925 and 2015: A Systematic Review and Meta-Regression Analysis
Helicobacter
Ishibashi F, Ichita C, Takasu A, Li R, Hagiwara Y, Matsuyama Y, Kemmoto Y, Kusano C, Inoue M, Yamamichi N, Ishikawa H, Gotoda T
doi: 10.1111/hel.70052
Helicobacter Pylori
Efficacy of Tegoprazan-Containing Sequential Eradication Treatment Compared to Esomeprazole-Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicrobial Resistance: A Prospective, Randomized, Single Tertiary Center Study
Helicobacter
Lee JW, Kim N, Lee J, Jo SY, Lee DH
doi: 10.1111/hel.13143
RECOMMENDED
Helicobacter Pylori
PROBIOTICS PRESCRIBED WITH HELICOBACTER PYLORI ERADICATION THERAPY IN EUROPE: USAGE PATTERN, EFFECTIVENESS, AND SAFETY: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg)
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Deza DC, Alcedo J, Lafuente M, López FJ, Perez-Aisa Á, Pavoni M, Tepes B, Jonaitis L, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Voynovan I, Bujanda L, Lucendo AJ, Jurecic NB, Denkovski M, Vologzanina L, Rodrigo L, Martínez-Domínguez SJ, Fadieienko G, Huguet JM, Abdulkhakov R, Abdulkhakov SR, Alcaide N, Velayos B, Hernández L, Bordin DS, Gasbarrini A, Kupcinskas J, Babayeva G, Gridnyev O, Leja M, Rokkas T, Marcos-Pinto R, Lerang F, Boltin D, Mestrovic A, Smith SM, Venerito M, Boyanova L, Milivojevic V, Doulberis M, Kunovsky L, Parra P, Cano-Català A, Moreira L, Nyssen OP, Megraud F, Morain CO, Gisbert JP, Hp-EuReg investigators
doi: 10.14309/ajg.0000000000003351
Inflammatory Bowel Disease
Comparative Efficacy of Biologics and Small Molecule Therapies in Improving Patient-Reported Outcomes in Ulcerative Colitis: Systematic Review and Network Meta-Analysis
Inflamm Bowel Dis
Shehab M, Hassan A, Alrashed F, Abbas A, Ma C, Narula N, Jairath V, Singh S, Bessissow T
doi: 10.1093/ibd/izae163
Inflammatory Bowel Disease
Immunogenicity and efficacy of subcutaneous infliximab monotherapy versus combination therapy in IBD: a systematic review and meta-analysis
Clin Gastroenterol Hepatol
Anjie SI, Gecse KB, Meloni CM, Vidal-Itriago A, Löwenberg M, D'Haens GR
doi: 10.1016/j.cgh.2025.03.021
Inflammatory Bowel Disease
Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis
Adv Ther
Dignass A, Ainsworth C, Hartz S, Dunnewind N, Redondo I, Sapin C, Kroep S, Halfpenny N, Arcà E, Hoque S
doi: 10.1007/s12325-024-03003-8